Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, today announced that company management will participate in the following conference and invited investors to participate by webcast.

  • Jefferies London Healthcare Conference, London Fireside chat on Tuesday, November 19, 2024 at 6:00 a.m. ET

The webcast can be accessed in the investor relations section of Exact Sciences’ website at www.exactsciences.com.

About Exact Sciences Corp.

A leading provider of cancer screening and diagnostic tests, Exact Sciences gives patients and health care professionals the clarity needed to take life-changing action earlier. Building on the success of the Cologuard® and Oncotype® tests, Exact Sciences is investing in its pipeline to develop innovative solutions for use before, during, and after a cancer diagnosis. For more information, visit ExactSciences.com, follow Exact Sciences on X @ExactSciences, or find Exact Sciences on LinkedIn and Facebook.

Erik Holznecht Exact Sciences Corp. investorrelations@exactsciences.com 608-800-6605

EXACT Sciences (NASDAQ:EXAS)
Historical Stock Chart
From Oct 2024 to Nov 2024 Click Here for more EXACT Sciences Charts.
EXACT Sciences (NASDAQ:EXAS)
Historical Stock Chart
From Nov 2023 to Nov 2024 Click Here for more EXACT Sciences Charts.